Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 109 Pages
Report ld: 3957482
Request Sample
Customized Report
The global market for Ivermectin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ivermectin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ivermectin API by region & country, by Type, and by Application.
The Ivermectin API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ivermectin API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ivermectin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ivermectin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ivermectin API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Ivermectin API Product Introduction
1.2 Global Ivermectin API Market Size Forecast
1.2.1 Global Ivermectin API Sales Value (2020-2031)
1.2.2 Global Ivermectin API Sales Volume (2020-2031)
1.2.3 Global Ivermectin API Sales Price (2020-2031)
1.3 Ivermectin API Market Trends & Drivers
1.3.1 Ivermectin API Industry Trends
1.3.2 Ivermectin API Market Drivers & Opportunity
1.3.3 Ivermectin API Market Challenges
1.3.4 Ivermectin API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ivermectin API Players Revenue Ranking (2024)
2.2 Global Ivermectin API Revenue by Company (2020-2025)
2.3 Global Ivermectin API Players Sales Volume Ranking (2024)
2.4 Global Ivermectin API Sales Volume by Company Players (2020-2025)
2.5 Global Ivermectin API Average Price by Company (2020-2025)
2.6 Key Manufacturers Ivermectin API Manufacturing Base and Headquarters
2.7 Key Manufacturers Ivermectin API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ivermectin API
2.9 Ivermectin API Market Competitive Analysis
2.9.1 Ivermectin API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ivermectin API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ivermectin API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 98%
3.1.2 Purity 99%
3.2 Global Ivermectin API Sales Value by Type
3.2.1 Global Ivermectin API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ivermectin API Sales Value, by Type (2020-2031)
3.2.3 Global Ivermectin API Sales Value, by Type (%) (2020-2031)
3.3 Global Ivermectin API Sales Volume by Type
3.3.1 Global Ivermectin API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ivermectin API Sales Volume, by Type (2020-2031)
3.3.3 Global Ivermectin API Sales Volume, by Type (%) (2020-2031)
3.4 Global Ivermectin API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Industry
4.1.2 Research Organization
4.1.3 Others
4.2 Global Ivermectin API Sales Value by Application
4.2.1 Global Ivermectin API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ivermectin API Sales Value, by Application (2020-2031)
4.2.3 Global Ivermectin API Sales Value, by Application (%) (2020-2031)
4.3 Global Ivermectin API Sales Volume by Application
4.3.1 Global Ivermectin API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ivermectin API Sales Volume, by Application (2020-2031)
4.3.3 Global Ivermectin API Sales Volume, by Application (%) (2020-2031)
4.4 Global Ivermectin API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Ivermectin API Sales Value by Region
5.1.1 Global Ivermectin API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ivermectin API Sales Value by Region (2020-2025)
5.1.3 Global Ivermectin API Sales Value by Region (2026-2031)
5.1.4 Global Ivermectin API Sales Value by Region (%), (2020-2031)
5.2 Global Ivermectin API Sales Volume by Region
5.2.1 Global Ivermectin API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ivermectin API Sales Volume by Region (2020-2025)
5.2.3 Global Ivermectin API Sales Volume by Region (2026-2031)
5.2.4 Global Ivermectin API Sales Volume by Region (%), (2020-2031)
5.3 Global Ivermectin API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ivermectin API Sales Value, 2020-2031
5.4.2 North America Ivermectin API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ivermectin API Sales Value, 2020-2031
5.5.2 Europe Ivermectin API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ivermectin API Sales Value, 2020-2031
5.6.2 Asia Pacific Ivermectin API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ivermectin API Sales Value, 2020-2031
5.7.2 South America Ivermectin API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ivermectin API Sales Value, 2020-2031
5.8.2 Middle East & Africa Ivermectin API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ivermectin API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ivermectin API Sales Value
6.2.1 Key Countries/Regions Ivermectin API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ivermectin API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ivermectin API Sales Value, 2020-2031
6.3.2 United States Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ivermectin API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ivermectin API Sales Value, 2020-2031
6.4.2 Europe Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ivermectin API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ivermectin API Sales Value, 2020-2031
6.5.2 China Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ivermectin API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ivermectin API Sales Value, 2020-2031
6.6.2 Japan Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ivermectin API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ivermectin API Sales Value, 2020-2031
6.7.2 South Korea Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ivermectin API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ivermectin API Sales Value, 2020-2031
6.8.2 Southeast Asia Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ivermectin API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ivermectin API Sales Value, 2020-2031
6.9.2 India Ivermectin API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ivermectin API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Tecoland
7.1.1 Tecoland Company Information
7.1.2 Tecoland Introduction and Business Overview
7.1.3 Tecoland Ivermectin API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Tecoland Ivermectin API Product Offerings
7.1.5 Tecoland Recent Development
7.2 Merck & Co
7.2.1 Merck & Co Company Information
7.2.2 Merck & Co Introduction and Business Overview
7.2.3 Merck & Co Ivermectin API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck & Co Ivermectin API Product Offerings
7.2.5 Merck & Co Recent Development
7.3 Samex Overseas
7.3.1 Samex Overseas Company Information
7.3.2 Samex Overseas Introduction and Business Overview
7.3.3 Samex Overseas Ivermectin API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Samex Overseas Ivermectin API Product Offerings
7.3.5 Samex Overseas Recent Development
7.4 Hovione
7.4.1 Hovione Company Information
7.4.2 Hovione Introduction and Business Overview
7.4.3 Hovione Ivermectin API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Hovione Ivermectin API Product Offerings
7.4.5 Hovione Recent Development
7.5 Hangzhou Think Chemical
7.5.1 Hangzhou Think Chemical Company Information
7.5.2 Hangzhou Think Chemical Introduction and Business Overview
7.5.3 Hangzhou Think Chemical Ivermectin API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Hangzhou Think Chemical Ivermectin API Product Offerings
7.5.5 Hangzhou Think Chemical Recent Development
7.6 Shandong Qilu King-Phar Pharmaceutical
7.6.1 Shandong Qilu King-Phar Pharmaceutical Company Information
7.6.2 Shandong Qilu King-Phar Pharmaceutical Introduction and Business Overview
7.6.3 Shandong Qilu King-Phar Pharmaceutical Ivermectin API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shandong Qilu King-Phar Pharmaceutical Ivermectin API Product Offerings
7.6.5 Shandong Qilu King-Phar Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Ivermectin API Industrial Chain
8.2 Ivermectin API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ivermectin API Sales Model
8.5.2 Sales Channel
8.5.3 Ivermectin API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ivermectin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 131
USD 3950.00
(Single User License)
The global Ivermectin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 131
USD 2900.00
(Single User License)
The global Ivermectin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 131
USD 4900.00
(Single User License)
The global market for Ivermectin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 89
USD 2900.00
(Single User License)
The global Ivermectin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 76
USD 4250.00
(Single User License)
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published Date: 2024-02-19
Pages: 98
USD 3950.00
(Single User License)
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published Date: 2024-01-11
Pages: 93
USD 2900.00
(Single User License)
The global market for Ivermectin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 131
The global Ivermectin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 131
The global Ivermectin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 131
The global market for Ivermectin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 89
The global Ivermectin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 76
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published: 2024-04-07
Pages: 89
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published: 2024-02-19
Pages: 98
Ivermectin API is a ingredients under potent inhibitor of the SARS-CoV-2 clinical isolate Australia/VIC01/2020.
Published: 2024-01-11
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now